Catalyst

Slingshot members are tracking this event:

DBV Technologies (DBVT) Expects to Complete Phase III PEPITES Trial Evaluating Viaskin Peanut in Children with Peanut Allergies in 2H 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
DBVT

100%

Additional Information

Additional Relevant Details Originally company expected data to be released in July 2017.
https://clinicaltria...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 07, 2017
Occurred Source:
Related Keywords Phase Iii Pepites Trial, Viaskin Peanut, Children With Peanut Allergies, Trial Completion